EDGEWELL PERSONAL CARE Co
EPCdata completeness 100%18 fiscal years on fileEDGEWELL PERSONAL CARE Co earns about 4% on invested capital, and has bought back 14% of its shares over 5 years. The applicable estimate puts fair value near $21.66 a share.Whether it’s worth owning at today’s price is the last question — and yours to answer, below.
| Figure | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|
| Revenue | $2.09B1 | $2.17B2 | $2.25B3 | $2.25B3 | $2.22B3 |
| Net income | $117.8M4 | $99.5M5 | $114.7M6 | $98.6M6 | $25.4M6 |
| Operating cash flow | $229M7 | $102M8 | −$216.1M9 | −$231M9 | $118.4M9 |
| Capital expenditure | $56.8M10 | $56.4M11 | $49.5M12 | $56.5M12 | $77M12 |
| Free cash flow (derived) | $172.2M7 | $45.6M8 | −$265.6M9 | −$287.5M9 | $41.4M9 |
| Total debt | $2.48B13 | $2.8B14 | $2.73B15 | $2.56B16 | $2.77B16 |
| Cash & equivalents | $479.2M17 | $188.7M18 | $216.4M19 | $209.1M19 | $225.7M20 |
| Diluted shares | 55.2M | 53.6M | 51.8M | 50.1M | 47.6M |
Superscripts are receipts. Each links to the SEC filing the number came from (full list at the bottom).
10 shares is a claim on $326.28 of net worth that earned you $5.34 and generated $8.7 of cash last year, against $582.63 of debt.
It earned an average 4% on invested capital over 5 years. Compare that to what it costs to fund the business.
seeing a moat in the numbers →Share count is down 14% over 5 years — management has been buying back stock, quietly handing owners a bigger slice. Total debt has risen 12% over the same window.
reading capital allocation →Signals, not verdicts — read from the filings above. Numbers don’t prove a moat; they show its footprint. You decide.
assumptions (8)
- riskFreeRate4.7%
- equityRiskPremium5.0%
- beta100.0%
- equityWeight85.0%
- costOfDebtSpread1.5%
- taxRate21.0%
- normalizedEarnings$99.5M
- growthAssumed0.0%
assumptions (1)
- grahamMultiplier2250.0%
Different models answer different questions — which to trust when →
- 10-K · period ending 2021-09-30 · accession 0001628280-23-040139 (Revenues)
- 10-K · period ending 2022-09-30 · accession 0001628280-24-047916 (Revenues)
- 10-K · period ending 2023-09-30 · accession 0001628280-25-052765 (Revenues)
- 10-K · period ending 2021-09-30 · accession 0001628280-23-040139 (NetIncomeLoss)
- 10-K · period ending 2022-09-30 · accession 0001628280-24-047916 (NetIncomeLoss)
- 10-K · period ending 2023-09-30 · accession 0001628280-25-052765 (NetIncomeLoss)
- 10-K · period ending 2021-09-30 · accession 0001628280-23-040139 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2022-09-30 · accession 0001628280-24-047916 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2023-09-30 · accession 0001628280-25-052765 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2021-09-30 · accession 0001628280-23-040139 (PaymentsToAcquireProductiveAssets)
- 10-K · period ending 2022-09-30 · accession 0001628280-24-047916 (PaymentsToAcquireProductiveAssets)
- 10-K · period ending 2023-09-30 · accession 0001628280-25-052765 (PaymentsToAcquireProductiveAssets)
- 10-K · period ending 2021-09-30 · accession 0001096752-22-000033 (LongTermDebtNoncurrent)
- 10-K · period ending 2022-09-30 · accession 0001628280-23-040139 (LongTermDebtNoncurrent)
- 10-K · period ending 2023-09-30 · accession 0001628280-24-047916 (LongTermDebtNoncurrent)
- 10-K · period ending 2024-09-30 · accession 0001628280-25-052765 (LongTermDebtNoncurrent)
- 10-K · period ending 2021-09-30 · accession 0001096752-22-000033 (CashAndCashEquivalentsAtCarryingValue)
- 10-K · period ending 2022-09-30 · accession 0001628280-23-040139 (CashAndCashEquivalentsAtCarryingValue)
- 10-K · period ending 2023-09-30 · accession 0001628280-24-047916 (CashAndCashEquivalentsAtCarryingValue)
- 10-K · period ending 2025-09-30 · accession 0001628280-25-052765 (CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents)